Proteomic and Metabolomic Changes in Psoriasis Preclinical and Clinical Aspects
Skin diseases such as psoriasis (Ps) and psoriatic arthritis (PsA) are immune-mediated inflammatory diseases. Overlap of autoinflammatory and autoimmune conditions hinders diagnoses and identifying personalized patient treatments due to different psoriasis subtypes and the lack of verified biomarker...
Main Authors: | Adrianna Radulska, Iwona Pelikant-Małecka, Kamila Jendernalik, Iwona T. Dobrucki, Leszek Kalinowski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/11/9507 |
Similar Items
-
Biomarkers of An Autoimmune Skin Disease—Psoriasis
by: Shan Jiang, et al.
Published: (2015-08-01) -
Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research
by: Munazza Ahmed, et al.
Published: (2022-12-01) -
Investigation of the protein expression level in lesions of patients with psoriasis vulgaris by proteomics technology
by: Junbo DU, et al.
Published: (2021-12-01) -
Metabolomic Differences between the Skin and Blood Sera of Atopic Dermatitis and Psoriasis
by: Liis Ilves, et al.
Published: (2022-10-01) -
Metabolomics Reveals Molecular Signatures for Psoriasis Biomarkers and Drug Targets Discovery
by: Song Q, et al.
Published: (2023-11-01)